Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II Trial.
Eva GinéFátima de la CruzAna Jiménez UbietoJavier López JiménezAlejandro Martin Martin Garcia-SanchoM José TerolEva González BarcaMaría CasanovaAdolfo de la FuenteAna Marin-NieblaAna MuntañolaTomás José González-LópezMarta AymerichXavier SetoainMontserrat Cortés-RomeraAmanda RotgerSonia RodríguezAlejandro Medina HerreraMiriam SanteroFerran NadeuSílvia BeàElias CampoArmondo López-GuillermoPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
-mutated cases.